GOLDENWELL BIOTECH, INC. 1Q 2026: Revenue $0 EPS $(0.00018) — 10-Q Summary
GOLDENWELL BIOTECH, INC. reported first-quarter 2026 results, remaining pre-revenue with Revenue of $0 and a net loss of $17606; diluted earnings per share were $(0.00018), an improvement from the year-ago quarter.Financial HighlightsBusiness HighlightsOriginal SEC Filing: GOLDENWELL BIOTECH, INC…